AVRAM SCHEINER
Pilots at Meadowood Cir, Saint Paul, MN

6689117, Feb 10, 2004

Dec 18, 2000

09/740129

Robert J. Sweeney - Woodbury MN
Avram Scheiner - Vadnais Heights MN

Cardiac Pacemakers, Inc. - St. Paul MN

A61M 3100

604503, 604 66, 6048901, 604 65, 600547, 607 3, 607 60

A drug delivery system and method in which an implantable medical device communicates with and controls an external drug delivery device with low energy potential signals. The implantable device generates potential signals modulated with digitally encoded command information by operating a current source to cause corresponding electrical potentials that can be sensed at the skin surface by the external drug delivery device. The drug delivery device then demodulates the sensed potentials and decodes the digital data to extract command information therefrom to deliver a drug accordingly.

6256541, Jul 3, 2001

Apr 17, 1998

9/062268

John E. Heil - White Bear Lake MN
Ronald W. Heil - Roseville MN
Avram Scheiner - Vadnais Heights MN
Yayun Lin - St. Paul MN
Lyle A. Bye - Lino Lakes MN
J. John Lattuca - Weybridge, GB

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 105

607123

An endocardial lead comprising an elongate body having a first defibrillation coil electrode, a second defibrillation coil electrode and a first pacing/sensing electrode. The first defibrillation coil electrode has a first end and a second end, where the first end is at or near the distal end of the elongate body and the second end spaced longitudinally from the distal end. The first pacing/sensing electrode is spaced longitudinally along the peripheral surface from the second end of the first defibrillation coil electrode. The second defibrillation coil electrode is spaced longitudinally along the peripheral surface from the first pacing/sensing electrode to afford positioning the first defibrillation coil longitudinally adjacent an apical location of the right ventricle of a heart with the first pacing/sensing electrode within the right ventricle of the heart and the second defibrillation coil within the right atrial chamber or a major vein leading to the right atrial chamber of the heart. The elongate body further includes a curved portion on which the first pacing/sensing electrode is positioned such that the first pacing/sensing electrode extends beyond the peripheral surface of the elongate body to engage the tissue of the heart. The first pacing/sensing electrode further includes a retaining element, where the retaining element is adapted to be embedded in the right ventricle of the heart to secure the first pacing/sensing electrode and the elongate body of the endocardial lead to the right ventricle of the heart.

8583235, Nov 12, 2013

Jun 12, 2012

13/494785

Qingsheng Zhu - Wexford PA, US
Avram Scheiner - Vadnais Heights MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/00

607 28

A system and method for cardiac rhythm management, which includes an electrode system having at least one electrode and control circuitry coupled to the electrode system from which a first cardiac signal is sensed. The control circuitry includes a pulse circuit to produce electrical pulses at a first value to be delivered to the electrode system in a first cardiac region. At least one cardiac signal is sensed from a second cardiac region, where the cardiac signal includes indications of cardiac depolarizations from the second cardiac region which occurs in direct reaction to the electrical pulses delivered to the first cardiac region. The first value of the electrical pulses are then modified by a pulse adjustment circuit when a cardiac depolarization which occurs in direct reaction to the electrical pulse delivered to the first cardiac region is detected from the second cardiac region.

8167811, May 1, 2012

Jan 11, 2011

13/004543

Avram Scheiner - Vadnais Heights MN, US
Qingsheng Zhu - Wexford PA, US
Arthur L. Olive - Stacy MN, US
Don Villalta - Minneapolis MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61B 5/02

600528, 600513

An apparatus for outputting heart sounds includes an implantable system and an external system. The implantable system includes a sensor for generating sensed signals representing detected heart sounds, an interface circuit and a control circuit for receiving the sensed signals, generating data representing the heart sounds therefrom, and transmitting the data to the external system via the interface circuit. The external system includes an interface circuit for communicating with the implantable system, and a control circuit for receiving the data representing the heart sounds and for generating control signals that cause an output device to generate outputs representing the sounds. The implantable system may also include a sensor(s) for detecting cardiac electrical signals. In this case, outputs representing the cardiac electrical signals are also output.

8634921, Jan 21, 2014

Feb 22, 2012

13/402196

Abhi V. Chavan - Maple Grove MN, US
Anthony V. Caparso - San Jose CA, US
Avram Scheiner - Vadnais Heights MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/05

607 44

One aspect of the present subject matter relates to an implantable medical device. An embodiment of the device comprises a rechargeable power supply adapted to be recharged through an ultrasound signal, a neural stimulator connected to the rechargeable power supply, and a controller connected to the rechargeable power supply. The neural stimulator is adapted to generate a neural stimulation signal for delivery to a neural stimulation target through an electrode. The controller is further connected to the neural stimulator to control the neural stimulator according to a neural stimulation protocol. Other aspects are provided herein.

2007006, Mar 22, 2007

Nov 16, 2006

11/600807

Avram Scheiner - Vadnais Heights MN, US
Ronald Heil - Roseville MN, US
Peter Kelley - Buffalo MN, US
Bruce Tockman - Scandia MN, US
Randy Westlund - Minneapolis MN, US
Jay Warren - North Oaks MN, US

A61N 1/05

607122000

A lead for monitoring or stimulating cardiac activity is provided. The lead is adapted for implantation on or about the heart within the coronary vasculature and for connection to a signal generator. The lead body has one or more electrodes associated therewith. The lead is constructed and arranged so that when it is implanted, the electrodes are housed in the coronary vasculature and urged into intimate contact a vessel wall.

8473076, Jun 25, 2013

Sep 6, 2011

13/225769

Imad Libbus - St. Paul MN, US
Avram Scheiner - Vadnais Heights MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/05, A61N 1/04

607148, 607149

An apparatus includes a flexible lead body extending from a proximal end to a distal end, an expandable electrode coupled proximate the distal end, the expandable electrode having an expanded diameter dimensioned to abut a wall of a pulmonary artery, and an implantable pulse generator electrically coupled to the expandable electrode. The expandable electrode includes a plurality of electrode zones. The plurality of zones can be tested to determine which zone delivers the best baroreflex response. At least one of the electrode zones can be selected to deliver a stimulation signal based on the testing. The implantable pulse generator is adapted to deliver a baroreflex stimulation signal to a baroreceptor in the pulmonary artery via the electrode.

2010019, Jul 29, 2010

Jan 27, 2009

12/360680

Avram Scheiner - Vadnais Heights MN, US
David E. Euler - Plymouth MN, US

A61N 1/36

607 62, 607 66

An implantable medical device and associated method deliver a therapy to an autonomic nerve. The therapy delivery includes delivering therapeutic low frequency (LF) electrical stimulation pulses to the autonomic nerve and delivering a high frequency electrical signal to the autonomic nerve during the LF frequency stimulation pulse delivery. The high frequency stimulation signal blocks activation of autonomic nerve fibers innervating a non-targeted tissue during the therapeutic LF stimulation pulse delivery.

7142920, Nov 28, 2006

May 25, 2004

10/853574

Avram Scheiner - Vadnais Heights MN, US
Donald Hopper - Maple Grove MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61N 1/30

607 17

An implantable cardiac device with an exertion level sensor is programmed to determine a heart rate appropriate for a given measured exertion level in accordance with a physiological model and/or previously collected physiologic data. The device then compares the model's heart rate with a measured intrinsic heart rate. Based upon this data, the device is able to recognize changes in the patient's heart rate response and predict or recognize a chronotropically incompetent condition.

7818051, Oct 19, 2010

Oct 26, 2007

11/925657

Aaron McCabe - Minneapolis MN, US
Avram Scheiner - Vadnais Heights MN, US
Geng Zhang - Newbury Park CA, US
Quan Ni - White Bear Lake MN, US
Douglas R. Daum - Oakdale MN, US
Yi Zhang - Blaine MN, US

Cardiac Pacemakers, Inc. - St. Paul MN

A61B 5/04

600522, 600509, 600515

An implantable medical device such as an implantable pacemaker or implantable cardioverter/defibrillator includes a programmable sensing circuit providing for sensing of a signal approximating a surface electrocardiogram (ECG) through implanted electrodes. With various electrode configurations, signals approximating various standard surface ECG signals are acquired without the need for attaching electrodes with cables onto the skin. The various electrode configurations include, but are not limited to, various combinations of intracardiac pacing electrodes, portions of the implantable medical device contacting tissue, and electrodes incorporated onto the surface of the implantable medical device.